Amneal Pharmaceuticals Statistics
Total Valuation
AMRX has a market cap or net worth of $2.60 billion. The enterprise value is $5.11 billion.
Important Dates
The next estimated earnings date is Friday, May 2, 2025, before market open.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRX has 309.97 million shares outstanding. The number of shares has increased by 75.42% in one year.
| Current Share Class | 309.97M |
| Shares Outstanding | 309.97M |
| Shares Change (YoY) | +75.42% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 49.08% |
| Owned by Institutions (%) | 41.22% |
| Float | 157.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.32 |
| PS Ratio | 0.92 |
| Forward PS | 0.88 |
| PB Ratio | -58.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.19 |
| P/OCF Ratio | 8.90 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.74, with an EV/FCF ratio of 21.76.
| EV / Earnings | n/a |
| EV / Sales | 1.83 |
| EV / EBITDA | 8.74 |
| EV / EBIT | 14.66 |
| EV / FCF | 21.76 |
Financial Position
The company has a current ratio of 1.41
| Current Ratio | 1.41 |
| Quick Ratio | 0.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.28 |
| Debt / FCF | 11.05 |
| Interest Coverage | 1.35 |
Financial Efficiency
Return on equity (ROE) is -881.26% and return on invested capital (ROIC) is 8.12%.
| Return on Equity (ROE) | -881.26% |
| Return on Assets (ROA) | 6.24% |
| Return on Invested Capital (ROIC) | 8.12% |
| Return on Capital Employed (ROCE) | 14.69% |
| Revenue Per Employee | $336,621 |
| Profits Per Employee | -$14,083 |
| Employee Count | 8,300 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 2.98 |
Taxes
In the past 12 months, AMRX has paid $18.86 million in taxes.
| Income Tax | 18.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.28% in the last 52 weeks. The beta is 1.05, so AMRX's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +38.28% |
| 50-Day Moving Average | 8.43 |
| 200-Day Moving Average | 8.09 |
| Relative Strength Index (RSI) | 46.15 |
| Average Volume (20 Days) | 1,907,765 |
Short Selling Information
The latest short interest is 3.20 million, so 1.03% of the outstanding shares have been sold short.
| Short Interest | 3.20M |
| Short Previous Month | 2.62M |
| Short % of Shares Out | 1.03% |
| Short % of Float | 2.03% |
| Short Ratio (days to cover) | 1.58 |
Income Statement
In the last 12 months, AMRX had revenue of $2.79 billion and -$116.89 million in losses. Loss per share was -$0.38.
| Revenue | 2.79B |
| Gross Profit | 1.02B |
| Operating Income | 348.36M |
| Pretax Income | -157.04M |
| Net Income | -116.89M |
| EBITDA | 584.55M |
| EBIT | 348.36M |
| Loss Per Share | -$0.38 |
Full Income StatementBalance Sheet
The company has $112.42 million in cash and $2.59 billion in debt, giving a net cash position of -$2.48 billion or -$8.00 per share.
| Cash & Cash Equivalents | 112.42M |
| Total Debt | 2.59B |
| Net Cash | -2.48B |
| Net Cash Per Share | -$8.00 |
| Equity (Book Value) | -44.54M |
| Book Value Per Share | -0.35 |
| Working Capital | 458.04M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $295.10 million and capital expenditures -$60.34 million, giving a free cash flow of $234.76 million.
| Operating Cash Flow | 295.10M |
| Capital Expenditures | -60.34M |
| Free Cash Flow | 234.76M |
| FCF Per Share | $0.76 |
Full Cash Flow StatementMargins
Gross margin is 36.35%, with operating and profit margins of 12.47% and -4.18%.
| Gross Margin | 36.35% |
| Operating Margin | 12.47% |
| Pretax Margin | -1.97% |
| Profit Margin | -4.18% |
| EBITDA Margin | 20.92% |
| EBIT Margin | 12.47% |
| FCF Margin | 8.40% |
Dividends & Yields
AMRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -75.42% |
| Shareholder Yield | -75.42% |
| Earnings Yield | -4.45% |
| FCF Yield | 8.94% |
Dividend DetailsAnalyst Forecast
The average price target for AMRX is $10.80, which is 28.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.80 |
| Price Target Difference | 28.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMRX has an Altman Z-Score of 1.41 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.41 |
| Piotroski F-Score | 6 |